Comparative absorption profiles of divalproex sodium delayed-release vs. extended-release tablets-clinical implications

被引：0
|
作者：
Dutta, S
Reed, RC
O Dea, R
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A189 / A190
页数：2
相关论文
共 50 条
  • [31] Comparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humans
    Sun, JX
    Niecestro, R
    Phillips, G
    Shen, J
    Lukacsko, P
    Friedhoff, L
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (02): : 198 - 204
  • [32] Comment on: Comparative dissolution profiles of two anti-emetic delayed-release dosage forms of doxylamine and pyridoxine: Xonvea® tablets vs. Cariban® capsules
    Urso, K.
    Saz-Leal, P.
    Dominguez, L. Zamorano
    Mangrella, M.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (22) : 8206 - 8208
  • [33] Single dose pharmacokinetics of divalproex sodium delayed release tablets in healthy volunteers
    Dutta, S
    Reed, RC
    O'Dea, R
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1202 - 1202
  • [34] Conversion from delayed-release sodium valproate to extended-release sodium valproate: Initial results and long-term follow-up
    McCabe, PH
    Michel, NC
    Mcnew, CD
    Lehman, EB
    [J]. EPILEPSY & BEHAVIOR, 2006, 8 (03) : 601 - 605
  • [35] Forgetting to take a daily dose of divalproex sodium extended-release tablets beyond 12 hours: What is a patient to do?
    Reed, RC
    Dutta, S
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1201 - 1201
  • [36] DEVELOPMENT OF AN INTERACTIVE PHARMACOKINETIC DOSE-DEPENDENT DURATION MODEL FOR DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE
    Po, Michelle
    Komolova, Marina
    Anderson, James C.
    Sallee, Floyd R.
    Warrington, Lewis E.
    Incledon, Bev
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S191 - S191
  • [37] In Silico Simulation of Dissolution Profiles for Development of Extended-Release Doxazosin Tablets
    Duque, Marcelo Dutra
    Issa, Michele Georges
    Silva, Daniela Amaral
    Barbosa, Eduardo Jose
    Lobenberg, Raimar
    Ferraz, Humberto Gomes
    [J]. DISSOLUTION TECHNOLOGIES, 2018, 25 (04): : 14 - 21
  • [38] Divalproex sodium extended-release tablets for migraine prophylaxis in adolescents: An open-label, long-term safety study
    Apostol, George
    Lewis, Donald
    Laforet, Genevieve A.
    Robieson, Weining Z.
    Fugate, Julie M.
    Abi-Saab, Walid
    Rappard, Fred
    Saltarelli, Mario
    [J]. NEUROLOGY, 2008, 70 (11) : A475 - A476
  • [39] Drug-Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended-Release Tablets in Healthy Participants and Patients with Psychiatric Disorders
    Remmerie, Bart
    Ariyawansa, Jay
    De Meulder, Marc
    Coppola, Danielle
    Berwaerts, Joris
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (06): : 683 - 692
  • [40] REAL-WORLD SAFETY PROFILE OF DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE FOR ADHD IN CHILDREN, ADOLESCENTS, AND ADULTS
    Childress, Ann Catherine
    Otcheretko, Victor
    Warrington, Lewis E.
    Barnes, Justin A.
    Gregg, Ryan A.
    Weddige, Karl
    DeSousa, Norberto J.
    Sallee, Floyd R.
    Incledon, Bev
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S213 - S213
12345